Lingual Tonsillectomy for Treatment of Pediatric Obstructive Sleep Apnea

Authors:

Abstract
Obstructive sleep apnea (OSA) in children covers a spectrum of respiratory disorders characterized by upper airway collapse during sleep.1,2 The pathogenesis of childhood OSA is mainly due to enlarged adenotonsillar tissues.3-5 Adenotonsillectomy is widely considered the first-line therapy for childhood sleep apnea.1,6,7 Treatment outcomes for adenotonsillectomy have been studied extensively.8-12 In 2006, a meta-analysis by Brietzke and Gallagher8 demonstrated that the mean change in the apnea-hypopnea index (AHI) after adenotonsillectomy was a reduction of 13.92 events per hour, with a success rate of 82.9%. A review article by Friedman et al9 in 2009 found that the mean change in the AHI after adenotonsillectomy was a reduction of 12.42 events per hour, with an overall success rate lower than commonly believed (59.8% for an AHI10 in 2016 by our research group demonstrated that adenotonsillectomy results in notable improvement in a number of sleep variables, with an overall success rate of 51% for a postoperative AHI less than 1. Other meta-analyses8-10 have shown that postoperative residual OSA remained in approximately half of the children treated with adenotonsillectomy. Therefore, additional treatment strategies are desirable for children with persistent OSA after adenotonsillectomy.13

This publication has 63 references indexed in Scilit: